Compound Library
Evidence-based research summaries across 9 categories.
ACTH-derived heptapeptide developed in Russia. Studied for nootropic effects, BDNF upregulation, stroke recovery, and neurological protection. Approved in Russia and Ukraine as a drug.
Synthetic analogue of immunomodulatory peptide tuftsin. Studied for anxiolytic effects, cognitive enhancement, and immune modulation without sedation or dependence.
Delta Sleep-Inducing Peptide — neuropeptide studied for sleep architecture improvement, stress reduction, and HPA axis modulation.
Hepatocyte growth factor receptor (HGF/c-Met) agonist peptide. Described in preclinical studies as millions of times more potent than BDNF for synaptogenesis. Studied for Alzheimer disease, cognitive enhancement, and neurological repair.
Proline-containing dipeptide nootropic studied for cognitive enhancement, neuroprotection, and anxiety reduction. Developed in Russia. Rapidly crosses BBB; active at nanogram doses. Different mechanism from racetam class.
Neuropeptide mixture derived from pig brain tissue. Contains BDNF, NGF, GDNF, CNTF, and other neurotrophic peptide fragments. Studied for Alzheimer's disease, traumatic brain injury, stroke recovery, and ADHD. Widely used in Russia and China.
PSD-95 inhibitor peptide studied for acute ischemic stroke neuroprotection. Designed to prevent excitotoxic neuronal death post-stroke. Phase 3 ESCAPE-NA1 trial completed with notable subgroup findings.
Polypeptide complex extracted from porcine/bovine cerebral cortex tissue. Contains multiple neurotrophic peptides. Studied for childhood cognitive development, stroke rehabilitation, and neuroprotection in Russia and Eastern Europe.